
John A. Ward
Examiner (ID: 10393)
| Most Active Art Unit | 2875 |
| Art Unit(s) | 2885, 2875 |
| Total Applications | 1293 |
| Issued Applications | 1015 |
| Pending Applications | 41 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4797102
[patent_doc_number] => 20080008688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'System and Method for Genetically Treating Cardiac Conduction Disturbances'
[patent_app_type] => utility
[patent_app_number] => 11/421301
[patent_app_country] => US
[patent_app_date] => 2006-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9664
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 61
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20080008688.pdf
[firstpage_image] =>[orig_patent_app_number] => 11421301
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/421301 | System and method for genetically treating cardiac conduction disturbances | May 30, 2006 | Issued |
Array
(
[id] => 5492067
[patent_doc_number] => 20090293138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'ANIMAL MODELS CARRYING TUMORS EXPRESSING HUMAN PROSTATE CANCER-SPECIFIC ANTIGEN AND METHOD FOR ANALYZING PREVENTION AND TREATMENT EFFICACY OF DENDRITIC CELLS-DERIVED IMMUNOTHERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 11/915737
[patent_app_country] => US
[patent_app_date] => 2006-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8615
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20090293138.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915737
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915737 | ANIMAL MODELS CARRYING TUMORS EXPRESSING HUMAN PROSTATE CANCER-SPECIFIC ANTIGEN AND METHOD FOR ANALYZING PREVENTION AND TREATMENT EFFICACY OF DENDRITIC CELLS-DERIVED IMMUNOTHERAPEUTICS | May 26, 2006 | Abandoned |
Array
(
[id] => 5687759
[patent_doc_number] => 20060286074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Methods for immunotherapy of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/441822
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22289
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286074.pdf
[firstpage_image] =>[orig_patent_app_number] => 11441822
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/441822 | Methods for immunotherapy of cancer | May 25, 2006 | Abandoned |
Array
(
[id] => 4495055
[patent_doc_number] => 07956238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-07
[patent_title] => 'Porcine pancreatic amylase gene promoter and transgenic pigs expressing heterologous digestive enzymes'
[patent_app_type] => utility
[patent_app_number] => 11/438979
[patent_app_country] => US
[patent_app_date] => 2006-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5801
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/956/07956238.pdf
[firstpage_image] =>[orig_patent_app_number] => 11438979
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/438979 | Porcine pancreatic amylase gene promoter and transgenic pigs expressing heterologous digestive enzymes | May 22, 2006 | Issued |
Array
(
[id] => 5367091
[patent_doc_number] => 20090304650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Repair of the Bone Marrow Vasculature'
[patent_app_type] => utility
[patent_app_number] => 11/914007
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18335
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304650.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914007
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914007 | Repair of the Bone Marrow Vasculature | May 10, 2006 | Abandoned |
Array
(
[id] => 5705200
[patent_doc_number] => 20060194248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Method of measuring human CYP3A inducibility'
[patent_app_type] => utility
[patent_app_number] => 11/414189
[patent_app_country] => US
[patent_app_date] => 2006-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4544
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194248.pdf
[firstpage_image] =>[orig_patent_app_number] => 11414189
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/414189 | Method of measuring human CYP3A inducibility | Apr 30, 2006 | Abandoned |
Array
(
[id] => 5292365
[patent_doc_number] => 20090025095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight'
[patent_app_type] => utility
[patent_app_number] => 11/918099
[patent_app_country] => US
[patent_app_date] => 2006-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6911
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20090025095.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918099
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918099 | Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight | Apr 24, 2006 | Abandoned |
Array
(
[id] => 292221
[patent_doc_number] => 07544510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-09
[patent_title] => 'Stem cells of the islets of Langerhans and their use in treating diabetes mellitus'
[patent_app_type] => utility
[patent_app_number] => 11/410412
[patent_app_country] => US
[patent_app_date] => 2006-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 17
[patent_no_of_words] => 18327
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/544/07544510.pdf
[firstpage_image] =>[orig_patent_app_number] => 11410412
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/410412 | Stem cells of the islets of Langerhans and their use in treating diabetes mellitus | Apr 23, 2006 | Issued |
Array
(
[id] => 5016134
[patent_doc_number] => 20070259343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Somatic transfer of modified genes to predict drug effects'
[patent_app_type] => utility
[patent_app_number] => 11/397346
[patent_app_country] => US
[patent_app_date] => 2006-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 13742
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259343.pdf
[firstpage_image] =>[orig_patent_app_number] => 11397346
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/397346 | Somatic transfer of modified genes to predict drug effects | Apr 2, 2006 | Abandoned |
Array
(
[id] => 5753484
[patent_doc_number] => 20060222633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Prevention, decrease, and/or treatment of immunoreactivity by depleting and/or inactivating antigen presenting cells in the host'
[patent_app_type] => utility
[patent_app_number] => 11/377647
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 26945
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20060222633.pdf
[firstpage_image] =>[orig_patent_app_number] => 11377647
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/377647 | Prevention, decrease, and/or treatment of immunoreactivity by depleting and/or inactivating antigen presenting cells in the host | Mar 16, 2006 | Abandoned |
Array
(
[id] => 5887551
[patent_doc_number] => 20060275270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'In vitro mucosal tissue equivalent'
[patent_app_type] => utility
[patent_app_number] => 11/375128
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 14339
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275270.pdf
[firstpage_image] =>[orig_patent_app_number] => 11375128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/375128 | In vitro mucosal tissue equivalent | Mar 14, 2006 | Abandoned |
Array
(
[id] => 6254316
[patent_doc_number] => 20100138936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Transgenic Mice and Use Thereof as an Experimental Model'
[patent_app_type] => utility
[patent_app_number] => 11/885429
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4128
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20100138936.pdf
[firstpage_image] =>[orig_patent_app_number] => 11885429
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885429 | Transgenic Mice and Use Thereof as an Experimental Model | Mar 5, 2006 | Abandoned |
Array
(
[id] => 5984586
[patent_doc_number] => 20110097330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Novel Gene Disruptions, Compostitions and Methods Relating Thereto'
[patent_app_type] => utility
[patent_app_number] => 11/722967
[patent_app_country] => US
[patent_app_date] => 2006-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 161
[patent_figures_cnt] => 161
[patent_no_of_words] => 285847
[patent_no_of_claims] => 141
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097330.pdf
[firstpage_image] =>[orig_patent_app_number] => 11722967
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/722967 | Novel Gene Disruptions, Compostitions and Methods Relating Thereto | Feb 26, 2006 | Abandoned |
Array
(
[id] => 5517087
[patent_doc_number] => 20090217394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Diabetes Model Animal'
[patent_app_type] => utility
[patent_app_number] => 11/884943
[patent_app_country] => US
[patent_app_date] => 2006-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10246
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20090217394.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884943
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884943 | Diabetes Model Animal | Feb 26, 2006 | Abandoned |
Array
(
[id] => 5336813
[patent_doc_number] => 20090053277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Cell Sheet Containing Mesenchymal Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 11/883243
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6391
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053277.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883243
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883243 | Cell sheet containing mesenchymal stem cells | Jan 26, 2006 | Issued |
Array
(
[id] => 5289969
[patent_doc_number] => 20090022699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Method Of Genotypically Modifying Cells By Administration Of RNA'
[patent_app_type] => utility
[patent_app_number] => 11/814271
[patent_app_country] => US
[patent_app_date] => 2006-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 36904
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11814271
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814271 | Method Of Genotypically Modifying Cells By Administration Of RNA | Jan 18, 2006 | Abandoned |
Array
(
[id] => 4813400
[patent_doc_number] => 20080194031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Alterations Utilizing Nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 11/795292
[patent_app_country] => US
[patent_app_date] => 2006-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 6652
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194031.pdf
[firstpage_image] =>[orig_patent_app_number] => 11795292
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/795292 | Alterations utilizing nanoparticles | Jan 17, 2006 | Issued |
Array
(
[id] => 452787
[patent_doc_number] => 07247475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-24
[patent_title] => 'Method for producing monoclonal antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/324255
[patent_app_country] => US
[patent_app_date] => 2006-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4368
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/247/07247475.pdf
[firstpage_image] =>[orig_patent_app_number] => 11324255
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/324255 | Method for producing monoclonal antibodies | Jan 3, 2006 | Issued |
Array
(
[id] => 83673
[patent_doc_number] => 07741300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Methods of using nucleic acid vector-lipid complexes'
[patent_app_type] => utility
[patent_app_number] => 11/320019
[patent_app_country] => US
[patent_app_date] => 2005-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 33
[patent_no_of_words] => 20038
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/741/07741300.pdf
[firstpage_image] =>[orig_patent_app_number] => 11320019
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/320019 | Methods of using nucleic acid vector-lipid complexes | Dec 26, 2005 | Issued |
Array
(
[id] => 7523068
[patent_doc_number] => 08026224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-27
[patent_title] => 'Tumor cells with increased immunogenicity and uses therfor'
[patent_app_type] => utility
[patent_app_number] => 11/313556
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 8
[patent_no_of_words] => 14978
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/026/08026224.pdf
[firstpage_image] =>[orig_patent_app_number] => 11313556
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/313556 | Tumor cells with increased immunogenicity and uses therfor | Dec 19, 2005 | Issued |